Challenging dermatologic conditions can take years to diagnose and almost as long to manage, according to a speaker at the ...

First described nearly 20 years ago, eosinophilic esophagitis (EoE ... incidence and increased recognition of this disorder. Treatment options available for patients with EoE include dietary ...

While there is no cure, treatments like dietary changes, medications, and medical procedures can reduce inflammation and ...

The FDA has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis.

which is being developed for the treatment of the rare disease eosinophilic granulomatosis with polyangiitis (EGPA). NS-229 is being investigated as a selective Janus kinase 1 (JAK1) inhibitor to ...

While treatment of EoE is complicated by a number ... 1 720 777 7457 Fax: +1 720 777 7277 [email protected]. Eosinophilic esophagitis (EoE) presents with a constellation of symptoms ...

NS-229 is currently being evaluated in a phase 2 trial in patients with eosinophilic granulomatosis with polyangiitis. The Food and Drug Administration (FDA) has granted Orphan Drug designation to ...